High Molecular Weight Chitosan-Complexed RNA Nanoadjuvant for Effective Cancer Immunotherapy

In Situ Nanoadjuvant-Assembled Tumor Vaccine for Preventing Long-Term Recurrence

(2019) Quoc-Viet Le et al.   ACS Nano

Recent Advances in Chitosan-Based Carriers for Gene Delivery

(2019) Ye Cao et al.   Marine Drugs

Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy

(2018) Rui Kuai et al.   BIOCONJUGATE CHEMISTRY

Effects of chitosan molecular weight on its antioxidant and antimutagenic properties

(2018) Shun-Hsien Chang et al.   CARBOHYDRATE POLYMERS

The revival of CpG oligonucleotide-based cancer immunotherapies

(2018) Tomasz Adamus et al.   Wspolczesna Onkologia-Contemporary Oncology

TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles

(2018) Mojca Frank-Bertoncelj et al.   Frontiers in Immunology

Needle-Free Immunization with Chitosan-Based Systems

(2018) Bijay Singh et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Novel application of trimethyl chitosan as an adjuvant in vaccine delivery

(2018) Anshu Malik et al.   International Journal of Nanomedicine

Local and global anatomy of antibody-protein antigen recognition

(2017) Meryl Wang et al.   JOURNAL OF MOLECULAR RECOGNITION

The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation

(2017) Yongbin Mou et al.   Nanoscale Research Letters

The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation

(2017) Yongbin Mou et al.   Nanoscale Research Letters

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons

(2016) Elizabeth. C. Carroll et al.   IMMUNITY

Vaccine adjuvants as potential cancer immunotherapeutics

(2016) Burcu Temizoz et al.   INTERNATIONAL IMMUNOLOGY

Beyond antigens and adjuvants: formulating future vaccines

(2016) Tyson J. Moyer et al.   JOURNAL OF CLINICAL INVESTIGATION

Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy

(2016) Qian Chen et al.   Nature Communications

Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists

(2015) Martin Kreutz et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration

(2015) Qingfeng Liu et al.   JOURNAL OF MEDICAL VIROLOGY

Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs

(2015) Rachid Ammi et al.   PHARMACOLOGY & THERAPEUTICS

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100

(2013) Kai Naumann et al.   Clinical & Developmental Immunology

Length of dsRNA (poly I:C) drives distinct innate immune responses, depending on the cell type

(2013) M. Firoz Mian et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants

(2013) Harm HogenEsch   Frontiers in Immunology

Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells

(2012) Christophe Dombu et al.   BIOMATERIALS

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

(2010) Malou Henriksen-Lacey et al.   JOURNAL OF CONTROLLED RELEASE

In Vitro Screening for Antimicrobial Activity of Chitosans and Chitooligosaccharides, Aiming at Potential Uses in Functional Textiles

(2010) João C. Fernandes   JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

(2009) Hae Yun Nam et al.   JOURNAL OF CONTROLLED RELEASE

Toll-like receptors and immune regulation: implications for cancer therapy

(2008) R-F Wang et al.   ONCOGENE